V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16626745 | 330006725 | EEI00 | 10 | x724 | 1 | 2014-08-21 | TRIAL | 330003495 | 330003482 | 330006726 |
| 16626746 | 330006727 | ECL01 | 100 | X721 | 1 | 2018-03-09 | NOT CHEMO | 330003509 | 330003486 | 330006728 |
| 16626747 | 330006727 | EKD50 | 196 | null | 1 | 2018-04-06 | VINCRISTINE | 330003509 | 330003486 | 330006728 |
| 16626748 | 330006727 | EJR | 2640 | X724 | 1 | 2018-04-06 | NOT CHEMO | 330003509 | 330003486 | 330006728 |
| 16626749 | 330006727 | EEI00 | 2040 | X724 | 1 | 2018-04-13 | CYTARABINE | 330003509 | 330003486 | 330006728 |
| 16626750 | 330006727 | EC4 | 5600 | X724 | 2 | 2018-04-13 | PEMBROLIZUMAB | 330003509 | 330003486 | 330006728 |
| 16626751 | 330006727 | EGU02 | 189 | X729 | 1 | 2018-04-13 | IFOSFAMIDE | 330003509 | 330003486 | 330006728 |
| 16626752 | 330006727 | EII | 120 | null | 1 | 2018-04-13 | CISPLATIN | 330003509 | 330003486 | 330006728 |
| 16626753 | 330006727 | EJR | 5000 | null | 1 | 2018-04-14 | FLUOROURACIL | 330003509 | 330003486 | 330006728 |
| 16626754 | 330006727 | EJQ | 1750 | null | 1 | 2018-04-14 | FLUOROURACIL | 330003509 | 330003486 | 330006728 |
| 16626755 | 330006727 | EJU04 | 8 | X724 | 2 | 2018-04-14 | STEROID | 330003509 | 330003486 | 330006728 |
| 16626756 | 330006727 | EEX02 | 5600 | null | 1 | 2018-04-15 | IFOSFAMIDE | 330003509 | 330003486 | 330006728 |
| 16626757 | 330006727 | EW2 | 8 | null | 1 | 2018-04-15 | NOT CHEMO | 330003509 | 330003486 | 330006728 |
| 16626758 | 330006727 | EEI00 | 4 | X724 | 1 | 2018-04-22 | MIFAMURTIDE | 330003509 | 330003486 | 330006728 |
| 16626759 | 330006728 | ECL02 | 100 | N/A | 1 | 2014-09-05 | CETUXIMAB | 330003517 | 330003487 | 330006729 |
| 16626760 | 330006728 | EJR | 3040 | X724 | 1 | 2014-09-19 | CYCLOPHOSPHAMIDE | 330003517 | 330003487 | 330006729 |
| 16626761 | 330006728 | EEI00 | 3280 | X724 | 1 | 2014-09-26 | MESNA | 330003517 | 330003487 | 330006729 |
| 16626762 | 330006728 | EEI00 | 2040 | X729 | 1 | 2014-09-26 | NOT CHEMO | 330003517 | 330003487 | 330006729 |
| 16626763 | 330006728 | ECL01 | null | X723 | 1 | 2014-09-26 | TRIAL | 330003517 | 330003487 | 330006729 |
| 16626764 | 330006729 | EOF | 20 | null | 1 | 2014-12-08 | CARBOPLATIN | 330003517 | 330003487 | 330006730 |
| 16626765 | 330006729 | E1UZ0 | 1 | null | 1 | 2014-12-09 | CYCLOPHOSPHAMIDE | 330003517 | 330003487 | 330006730 |
| 16626766 | 330006729 | ECL01 | 3280 | X729 | 1 | 2014-12-17 | TEMOZOLOMIDE | 330003517 | 330003487 | 330006730 |
| 16626767 | 330006730 | ECL02 | 100 | null | 2 | 2017-12-19 | NOT CHEMO | 330003521 | 330003490 | 330006731 |
| 16626768 | 330006730 | ERS12 | 1.05 | X721 | 1 | 2017-12-19 | VINCRISTINE | 330003521 | 330003490 | 330006731 |
| 16626769 | 330006730 | EEI00 | 1.05 | null | 1 | 2017-12-19 | AVELUMAB | 330003521 | 330003490 | 330006731 |
| 16626770 | 330006730 | EEI00 | 100 | X724 | 1 | 2017-12-19 | CYTARABINE | 330003521 | 330003490 | 330006731 |
| 16626771 | 330006730 | EKA | 170 | X724 | 1 | 2017-12-20 | NAB-PACLITAXEL | 330003521 | 330003490 | 330006731 |
| 16626772 | 330006730 | EGU02 | 15 | X724 | 1 | 2017-12-20 | DOXORUBICIN | 330003521 | 330003490 | 330006731 |
| 16626773 | 330006730 | EQ3 | 150 | X721 | 1 | 2017-12-20 | DOCETAXEL | 330003521 | 330003490 | 330006731 |
| 16626774 | 330006730 | EE813 | 40 | X724 | 1 | 2017-12-20 | NOT CHEMO | 330003521 | 330003490 | 330006731 |
| 16626775 | 330006730 | EE813 | 164 | X724 | 1 | 2017-12-20 | CISPLATIN | 330003521 | 330003490 | 330006731 |
| 16626778 | 330006733 | EKA | 10 | X721 | 1 | 2017-10-01 | IPILIMUMAB | 330003531 | 330012339 | 330006734 |
| 16626779 | 330006733 | E1UZ0 | 1320 | X729 | 1 | 2017-10-01 | NOT CHEMO | 330003531 | 330012339 | 330006734 |
| 16626780 | 330006734 | ECL01 | 160 | X724 | 1 | 2018-02-28 | DOXORUBICIN | 330003531 | 330012339 | 330006735 |
| 16626781 | 330006736 | EZ102 | 170 | X724 | 1 | 2014-05-20 | MESNA | 330003536 | 330003495 | 330006737 |
| 16626782 | 330006736 | EUZ | 170 | X721 | 1 | 2014-05-20 | DAUNORUBICIN | 330003536 | 330003495 | 330006737 |
| 16626783 | 330006737 | ECL02 | 160 | X729 | 9 | 2016-11-16 | STEROID | 330003549 | 330003496 | 330006738 |
| 16626784 | 330006737 | ED301 | 290 | null | 1 | 2016-11-30 | CYTARABINE | 330003549 | 330003496 | 330006738 |
| 16626785 | 330006737 | EEI00 | 68 | X721 | 1 | 2016-11-30 | IFOSFAMIDE | 330003549 | 330003496 | 330006738 |
| 16626786 | 330006737 | EK1EN | 814.5 | X721 | 5 | 2016-11-30 | ETOPOSIDE | 330003549 | 330003496 | 330006738 |
| 16626787 | 330006737 | EUJ01 | 1.9 | X721 | 2 | 2016-11-30 | ETOPOSIDE | 330003549 | 330003496 | 330006738 |
| 16626788 | 330006737 | EEI00 | 3000 | null | 1 | 2016-11-30 | ETOPOSIDE | 330003549 | 330003496 | 330006738 |
| 16626789 | 330006737 | ETG01 | 3550 | null | 1 | 2016-12-01 | FLUOROURACIL | 330003549 | 330003496 | 330006738 |
| 16626790 | 330006737 | EE813 | 120 | null | 1 | 2016-12-02 | DOCETAXEL | 330003549 | 330003496 | 330006738 |
| 16626791 | 330006737 | EE813 | 1000 | X729 | 1 | 2016-12-02 | NOT CHEMO | 330003549 | 330003496 | 330006738 |
| 16626792 | 330006739 | EOF | 1650 | X292 | 1 | 2013-09-09 | NOT CHEMO | 330003558 | 330003497 | 330006740 |
| 16626793 | 330006739 | EEI00 | 4560 | X724 | 1 | 2013-09-09 | ETOPOSIDE | 330003558 | 330003497 | 330006740 |
| 16626794 | 330006739 | EEI00 | 1650 | X724 | 1 | 2013-09-09 | ETOPOSIDE | 330003558 | 330003497 | 330006740 |
| 16626795 | 330006739 | EE813 | 4320 | X721 | 1 | 2013-09-09 | TRIAL | 330003558 | 330003497 | 330006740 |
| 16626796 | 330006739 | EON | 1.9 | null | 1 | 2013-09-09 | ETOPOSIDE | 330003558 | 330003497 | 330006740 |